Table 1.
Demographic and clinic features of the cohort.
| Characteristic | Number (%) |
|---|---|
| Total Cohort | 20 |
| Sex | |
| Female | 17 (85) |
| Current Age (years) | |
| Range | 15–59 |
| Mean ± SD | 34.40 ± 11.3 |
| Median | 32.0 |
| Age at onset (years) | |
| ≤18 | 7(35) |
| Range | 8.0–58.0 |
| Mean | 27.80±13.71 |
| Median | 25.5 |
| EDSS | |
| Range | 0.0–9.0 |
| Mean ± SD | 4.63±2.79 |
| Median | 4.25 |
| Antibody serostatus | |
| AQP4 seropositive | 10 (50) |
| AQP4 low positive | 4 (20) |
| AQP4 seronegative | 10 (50) |
| Duration of disease (years) | |
| Range | 0.25–25.0 |
| Mean | 6.82±7.43 |
| Median | 3.50 |
| Number of relapses | |
| ≤2 | 6 |
| >2 | 14 |
| Range | 1.0–15.0 |
| Mean | 4.55±3.62 |
| Median | 3.2 |
| Presenting symptom | |
| Optic neuritis | 8 (40) |
| Transverse myelitis | 7(35) |
| Brainstem | 5(25) |
| Area postrema | 5(25) |
| A DEM-like | 1(5) |
| Optic neuritis + Transverse myelitis | 1(5) |